Other Earnings and Cash Flow Stats:
ACCURAY INC ( ARAY ) Net Income TTM ($MM) is -16.53
ACCURAY INC ( ARAY ) Operating Income TTM ($MM) is -3.86
ACCURAY INC ( ARAY ) Owners' Earnings Annual ($MM) is 0.00
ACCURAY INC ( ARAY ) Current Price to Owners' Earnings ratio is 0.00
ACCURAY INC ( ARAY ) EBITDA TTM ($MM) is 2.26
ACCURAY INC ( ARAY ) EBITDA Margin is 0.91%
Capital Allocation:
ACCURAY INC ( ARAY ) has paid 0.00 dividends per share and bought back -3.67 million shares in the past 12 months
ACCURAY INC ( ARAY ) has reduced its debt by 33.962 million USD in the last 12 months
Capital Structure:
ACCURAY INC ( ARAY ) Interest-bearing Debt ($MM) as of last quarter is 177
ACCURAY INC ( ARAY ) Annual Working Capital Investments ($MM) are 4
ACCURAY INC ( ARAY ) Book Value ($MM) as of last quarter is 45
ACCURAY INC ( ARAY ) Debt/Capital as of last quarter is 391%
Other Balance Sheet Stats:
ACCURAY INC ( ARAY ) has 59 million in cash on hand as of last quarter
ACCURAY INC ( ARAY ) has 201 million of liabilities due within 12 months, and long term debt 170 as of last quarter
ACCURAY INC ( ARAY ) has 100 common shares outstanding as of last quarter
ACCURAY INC ( ARAY ) has 0 million USD of preferred stock value
Academic Scores:
ACCURAY INC ( ARAY ) Altman Z-Score is -0.03 as of last quarter
ACCURAY INC ( ARAY ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
ACCURAY INC ( ARAY ) largest shareholder is owning shares at 0.00 ($MM) value
Pervaiz Ali(an insider) Sold 8404 shares of ACCURAY INC ( ARAY ) for the amount of $17276.10 on 2024-09-04
2.87% of ACCURAY INC ( ARAY ) is held by insiders, and 60.70% is held by institutions
ACCURAY INC ( ARAY ) went public on 2007-02-08
Other ACCURAY INC ( ARAY ) financial metrics:
FCF:-14.24
Unlevered Free Cash Flow:0.00
EPS:-0.16
Operating Margin:-2.12
Gross Profit Margin:33.94
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-34.97
Beta:1.69
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About ACCURAY INC ( ARAY ) :
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
DISCLAIMER
This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.